De-Paula, V. J., Radanovic, M., Diniz, B. S. & Forlenza, O. V. Alzheimer’s disease. Subcell. Biochem. 65, 329–352 (2012).Article
CAS
PubMed
Google Scholar
Ju, Y. & Tam, K. Y. Pathological mechanisms and therapeutic strategies for Alzheimer’s disease. Neural Regen. Res. 17, 543–549 (2022).Article
CAS
PubMed
Google Scholar
Lane, C. A., Hardy, J. & Schott, J. M. Alzheimer’s disease. Eur. J. Neurol. 25, 59–70 (2018).Article
CAS
PubMed
Google Scholar
Gauthier, S. et al. World Alzheimer Report 2022. Alzheimer’s disease International https://www.alzint.org/resource/world-alzheimer-report-2022 (2022).2023 Alzheimer’s disease facts and figures. Alzheimers Dement. J. Alzheimers Assoc. 19, 1598–1695 (2023).Hardy, J. A. & Higgins, G. A. Alzheimer’s disease: The amyloid cascade hypothesis. Science 256, 184–185 (1992).Article
ADS
CAS
PubMed
Google Scholar
Muralidar, S., Ambi, S. V., Sekaran, S., Thirumalai, D. & Palaniappan, B. Role of tau protein in Alzheimer’s disease: The prime pathological player. Int. J. Biol. Macromol. 163, 1599–1617 (2020).Article
CAS
PubMed
Google Scholar
Lin, M. T. & Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787–795 (2006).Article
ADS
CAS
PubMed
Google Scholar
Chen, Z. & Zhong, C. Oxidative stress in Alzheimer’s disease. Neurosci. Bull. 30, 271–281 (2014).Article
CAS
PubMed
PubMed Central
Google Scholar
Preeti, K., Sood, A. & Fernandes, V. Metabolic regulation of glia and their neuroinflammatory role in Alzheimer’s disease. Cell. Mol. Neurobiol. 42, 2527–2551 (2022).Article
CAS
PubMed
Google Scholar
Neurology, T. L. Treatment for Alzheimer’s disease: Time to get ready. Lancet Neurol. 22, 455 (2023).Article
Google Scholar
Tian, S. et al. Exploring pharmacological active ingredients of traditional Chinese medicine by pharmacotranscriptomic map in ITCM. Brief. Bioinform. 24, bbad027 (2023).Article
PubMed
Google Scholar
Tian, S. et al. COIMMR: A computational framework to reveal the contribution of herbal ingredients against human cancer via immune microenvironment and metabolic reprogramming. Brief. Bioinform. 24, bbad346 (2023).Article
PubMed
PubMed Central
Google Scholar
Zheng, T., Liu, Q., Xing, F., Zeng, C. & Wang, W. Disulfidptosis: A new form of programmed cell death. J. Exp. Clin. Cancer Res. CR 42, 137 (2023).Article
CAS
PubMed
Google Scholar
Zhao, S. et al. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework. Front. Endocrinol. 14, 1180404 (2023).Article
Google Scholar
Wang, Y., Deng, Y., Xie, H. & Cao, S. Hub gene of disulfidptosis-related immune checkpoints in breast cancer. Med. Oncol. Northwood Lond. Engl. 40, 222 (2023).Article
CAS
Google Scholar
Wang, T. et al. Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profile. Int. Immunopharmacol. 120, 110368 (2023).Article
CAS
PubMed
Google Scholar
Zhang, L. et al. Development of tumor-evolution-targeted anticancer therapeutic nanomedicineEVT. Chem 10, 1337–1356 (2024).Article
CAS
Google Scholar
Ma, S., Wang, D. & Xie, D. Identification of disulfidptosis-related genes and subgroups in Alzheimer’s disease. Front. Aging Neurosci. 15, 1236490 (2023).Article
CAS
PubMed
PubMed Central
Google Scholar
Davis, S. & Meltzer, P. S. GEOquery: A bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinforma. Oxf. Engl. 23, 1846–1847 (2007).Article
Google Scholar
Narayanan, M. et al. Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases. Mol. Syst. Biol. 10, 743 (2014).Article
PubMed
PubMed Central
Google Scholar
McKay, E. C. et al. Peri-infarct upregulation of the oxytocin receptor in vascular dementia. J. Neuropathol. Exp. Neurol. 78, 436–452 (2019).Article
CAS
PubMed
PubMed Central
Google Scholar
Liang, W. S. et al. Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. Physiol. Genom. 28, 311–322 (2007).Article
CAS
Google Scholar
Liang, G. et al. Nanomedomics. ACS Nano 18, 10979–11024 (2024).Article
CAS
PubMed
Google Scholar
Liu, X. et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat. Cell Biol. 25, 404–414 (2023).Article
CAS
PubMed
PubMed Central
Google Scholar
Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).Article
PubMed
PubMed Central
Google Scholar
Altmann, A., Toloşi, L., Sander, O. & Lengauer, T. Permutation importance: A corrected feature importance measure. Bioinforma. Oxf. Engl. 26, 1340–1347 (2010).Article
CAS
Google Scholar
Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov. Camb. Mass 2, 100141 (2021).CAS
Google Scholar
Schober, P. & Vetter, T. R. Logistic regression in medical research. Anesth. Analg. 132, 365–366 (2021).Article
PubMed
PubMed Central
Google Scholar
Robin, X. et al. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 12, 77 (2011).Article
Google Scholar
Chen, B., Khodadoust, M. S., Liu, C. L., Newman, A. M. & Alizadeh, A. A. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol. Biol. Clifton NJ 1711, 243–259 (2018).Article
CAS
Google Scholar
Nguyen, T. et al. GraphDTA: Predicting drug-target binding affinity with graph neural networks. Bioinforma. Oxf. Engl. 37, 1140–1147 (2021).Article
CAS
Google Scholar
Wishart, D. S. et al. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074–D1082 (2018).Article
CAS
PubMed
Google Scholar
UniProt Consortium. UniProt: The universal protein knowledgebase in 2023. Nucleic Acids Res. 51, D523–D531 (2023).Article
Google Scholar
Liu, Y. et al. CB-Dock2: Improved protein–ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res. 50, W159–W164 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455–461 (2010).Article
CAS
PubMed
PubMed Central
Google Scholar
Andreone, B. J., Larhammar, M. & Lewcock, J. W. Cell death and neurodegeneration. Cold Spring Harb. Perspect. Biol. 12, a036434 (2020).Article
CAS
PubMed
PubMed Central
Google Scholar
Montini, E. et al. A novel human serine-threonine phosphatase related to the Drosophila retinal degeneration C (rdgC) gene is selectively expressed in sensory neurons of neural crest origin. Hum. Mol. Genet. 6, 1137–1145 (1997).Article
CAS
PubMed
Google Scholar
Herzig, S. & Neumann, J. Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol. Rev. 80, 173–210 (2000).Article
CAS
PubMed
Google Scholar
Srivastava, S., Ahmad, R. & Khare, S. K. Alzheimer’s disease and its treatment by different approaches: A review. Eur. J. Med. Chem. 216, 113320 (2021).Article
CAS
PubMed
Google Scholar
Uittenbogaard, M., Baxter, K. K. & Chiaramello, A. The neurogenic basic helix–loop–helix transcription factor NeuroD6 confers tolerance to oxidative stress by triggering an antioxidant response and sustaining the mitochondrial biomass. ASN Neuro 2, e00034 (2010).Article
PubMed
PubMed Central
Google Scholar
Wallace, D. C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu. Rev. Genet. 39, 359–407 (2005).Article
CAS
PubMed
PubMed Central
Google Scholar
Satoh, J.-I., Yamamoto, Y., Asahina, N., Kitano, S. & Kino, Y. RNA-Seq data mining: Downregulation of NeuroD6 serves as a possible biomarker for Alzheimer’s disease brains. Dis. Markers 2014, 123165 (2014).Article
PubMed
PubMed Central
Google Scholar
Fowler, K. D. et al. Leveraging existing data sets to generate new insights into Alzheimer’s disease biology in specific patient subsets. Sci. Rep. 5, 14324 (2015).Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Wang, C. et al. Effect of vasoactive intestinal peptide (VIP) on NKG2D signal pathway and its contribution to immune escape of MKN45 cells. Sci. World J. 2013, 429545 (2013).Article
Google Scholar
Villanueva-Romero, R. et al. Human CD4+CD45RA+ T cells behavior after in vitro activation: Modulatory role of vasoactive intestinal peptide. Int. J. Mol. Sci. 23, 2346 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Brenneman, D. E. et al. Vasoactive intestinal peptide. Link between electrical activity and glia-mediated neurotrophism. Ann. N. Y. Acad. Sci. 897, 17–26 (1999).Article
ADS
CAS
PubMed
Google Scholar
White, C. M., Ji, S., Cai, H., Maudsley, S. & Martin, B. Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders. CNS Neurol. Disord. Drug Targets 9, 661–666 (2010).Article
CAS
PubMed
PubMed Central
Google Scholar
Deng, G. & Jin, L. The effects of vasoactive intestinal peptide in neurodegenerative disorders. Neurol. Res. 39, 65–72 (2017).Article
CAS
PubMed
Google Scholar
Nowak, J. Z., Jozwiak-Bebenista, M. & Bednarek, K. Effects of PACAP and VIP on cyclic AMP formation in rat neuronal and astrocyte cultures under normoxic and hypoxic condition. Peptides 28, 1706–1712 (2007).Article
CAS
PubMed
Google Scholar
Saus, E. et al. Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients. J. Psychiatr. Res. 44, 971–978 (2010).Article
PubMed
Google Scholar
Gonzalez-Rey, E., Chorny, A., Fernandez-Martin, A., Varela, N. & Delgado, M. Vasoactive intestinal peptide family as a therapeutic target for Parkinson’s disease. Expert Opin. Ther. Targets 9, 923–929 (2005).Article
CAS
PubMed
Google Scholar
Goff, K. M. & Goldberg, E. M. A role for vasoactive intestinal peptide interneurons in neurodevelopmental disorders. Dev. Neurosci. 43, 168–180 (2021).Article
CAS
PubMed
Google Scholar
Chowdhury, U. R., Samant, R. S., Fodstad, O. & Shevde, L. A. Emerging role of nuclear protein 1 (NUPR1) in cancer biology. Cancer Metastasis Rev. 28, 225–232 (2009).Article
CAS
PubMed
Google Scholar
Xu, X. et al. Nupr1 modulates methamphetamine-induced dopaminergic neuronal apoptosis and autophagy through CHOP-Trib3-mediated endoplasmic reticulum stress signaling pathway. Front. Mol. Neurosci. 10, 203 (2017).Article
PubMed
PubMed Central
Google Scholar
Leone, A. et al. The Gem GTP-binding protein promotes morphological differentiation in neuroblastoma. Oncogene 20, 3217–3225 (2001).Article
CAS
PubMed
Google Scholar
Mulder, J. et al. Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease. Brain 134, 1041–1060 (2011).Article
PubMed
PubMed Central
Google Scholar
Li, Y. et al. Implications of GABAergic neurotransmission in Alzheimer’s disease. Front. Aging Neurosci. 8, 31 (2016).Article
PubMed
PubMed Central
Google Scholar
Sun, E., Motolani, A., Campos, L. & Lu, T. The pivotal role of NF-kB in the pathogenesis and therapeutics of Alzheimer’s disease. Int. J. Mol. Sci. 23, 8972 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Chen, X. & Holtzman, D. M. Emerging roles of innate and adaptive immunity in Alzheimer’s disease. Immunity 55, 2236–2254 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Silvin, A. et al. Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration. Immunity 55, 1448-1465.e6 (2022).Article
CAS
PubMed
Google Scholar
Zenaro, E. et al. Neutrophils promote Alzheimer’s disease-like pathology and cognitive decline via LFA-1 integrin. Nat. Med. 21, 880–886 (2015).Article
CAS
PubMed
Google Scholar
Liu, P. et al. Biomimetic dendrimer-peptide conjugates for early multi-target therapy of Alzheimer’s disease by inflammatory microenvironment modulation. Adv. Mater. 33, 2100746 (2021).Article
CAS
Google Scholar
Thawkar, B. S. & Kaur, G. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer’s disease. J. Neuroimmunol. 326, 62–74 (2019).Article
CAS
PubMed
Google Scholar
Kubin, A., Wierrani, F., Burner, U., Alth, G. & Grünberger, W. Hypericin—The facts about a controversial agent. Curr. Pharm. Des. 11, 233–253 (2005).Article
CAS
PubMed
Google Scholar
Zhang, M., Wang, Y., Qian, F., Li, P. & Xu, X. Hypericin inhibits oligomeric amyloid β42-induced inflammation response in microglia and ameliorates cognitive deficits in an amyloid β injection mouse model of Alzheimer’s disease by suppressing MKL1. Biochem. Biophys. Res. Commun. 481, 71–76 (2016).Article
CAS
PubMed
Google Scholar
Dong, X. et al. Emodin: A review of its pharmacology, toxicity and pharmacokinetics. Phytother. Res. 30, 1207–1218 (2016).Article
CAS
PubMed
PubMed Central
Google Scholar
Ho, T.-Y., Wu, S.-L., Chen, J.-C., Li, C.-C. & Hsiang, C.-Y. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res. 74, 92–101 (2007).Article
CAS
PubMed
Google Scholar
Li, Z. et al. Neuroprotective effect of emodin against Alzheimer’s disease via Nrf2 signaling in U251 cells and APP/PS1 mice. Mol. Med. Rep. 23, 108 (2021).Article
PubMed
Google Scholar
Wang, L. et al. Emodin inhibits aggregation of amyloid-β peptide 1–42 and improves cognitive deficits in Alzheimer’s disease transgenic mice. J. Neurochem. 157, 1992–2007 (2021).Article
CAS
PubMed
Google Scholar
Howlett, D. R., George, A. R., Owen, D. E., Ward, R. V. & Markwell, R. E. Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer β-amyloid fibril formation. Biochem. J. 343, 419–423 (1999).Article
CAS
PubMed
PubMed Central
Google Scholar